Literature DB >> 6541920

[Metronidazole concentration of the cerebrospinal fluid from slightly inflamed meninges].

H G Hoffmann, D Förster, B Muirhead.   

Abstract

The concentrations of metronidazole (Clont i.v.) in the cerebrospinal fluid were measured in 12 patients with viral meningitis or subsiding bacterial meningitis after a single infusion of 500 mg lasting 20 min. 1 h after infusion the CSF-concentrations were between 2,3 micrograms/ml and 7,4 micrograms/ml and 2 h after infusion between 6,5 micrograms/ml and 8,6 micrograms/ml. They attained 45,9% respectively 75,9% of the corresponding serum concentrations. Because the minimal inhibitory concentrations of the most important obligate anaerobic gram-negative bacteria are attained, it appears that metronidazole can be used for the treatment of bacterial meningitis caused by these pathogens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541920

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

Review 1.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 2.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

3.  Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.

Authors:  Marion Soto; Clémence Herzog; Julian A Pacheco; Shiho Fujisaka; Kevin Bullock; Clary B Clish; C Ronald Kahn
Journal:  Mol Psychiatry       Date:  2018-06-18       Impact factor: 15.992

4.  Comparison of the Utility of RP-TLC Technique and Different Computational Methods to Assess the Lipophilicity of Selected Antiparasitic, Antihypertensive, and Anti-inflammatory Drugs.

Authors:  Alina Pyka-Pająk; Wioletta Parys; Małgorzata Dołowy
Journal:  Molecules       Date:  2019-09-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.